Compositions for modulating C9ORF72 expression
US9605263B2 · kind B2 · utility
17Cited by
18References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 15, 2016 |
| Grant date | Mar 28, 2017 |
| Priority date | — |
| Expiry date | Apr 15, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compositions and methods for reducing expression of C9ORF72 mRNA and protein in an animal. Such methods are useful to treat, prevent, ameliorate, or slow progression of neurodegenerative diseases in an individual in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.